This educational activity will use clinical case vignettes of patients with type 2 diabetes mellitus to illustrate how insulin therapy can be individualized, clinical inertia can be avoided, and initiation or intensification of insulin therapy can lead to positive outcomes in the ambulatory setting. Discussion of treatment options will include consideration of the progressive nature of type 2 diabetes mellitus, current treatment guidelines, and pharmacokinetic and pharmacodynamic characteristics of new insulin formulations and delivery methods.

• Describe the pathophysiology and progressive nature of type 2 diabetes and the implications for the use of different insulin products.
• Design drug regimens to achieve goal glycemic patterns and avoid clinical inertia and hypoglycemia.
• Explain the logical use of insulin therapy in ambulatory patients with type 2 diabetes mellitus in the context of various clinical case vignettes.

Welcome and Introduction
Curtis L. Triplitt, Pharm.D., CDE

New and Emerging Diabetes Therapy: Choosing the Right Insulin for Your Patient
Curtis L. Triplitt, Pharm.D., CDE

Clinical Case Vignettes: Strategies to Avoid Clinical Inertia and Hypoglycemia
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE

Clinical Case Vignettes: Individualization of Insulin Therapy for Patients with Type 2 Diabetes Mellitus
Joshua J. Neumiller, Pharm.D., CDE, FASCP

Panel Discussion: Questions and Answers
All Faculty

This continuing pharmacy education activity was planned to meet the needs of pharmacists with an interest in diabetes management and new drug therapies who practice in hospitals, ambulatory care clinics, specialty pharmacies, and community pharmacies.